Drug
Dolutegravir Sodium And Rilpivirine Hydrochloride
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Anhedonia | 251 | 115.2 | 134.4 | signal |
| 2 | Economic Problem | 84 | 66.0 | 69.3 | signal |
| 3 | Osteopenia | 69 | 54.7 | 56.9 | signal |
| 4 | End Stage Renal Disease | 83 | 54.5 | 57.2 | signal |
| 5 | Decreased Activity | 32 | 36.1 | 36.7 | signal |
| 6 | Quality Of Life Decreased | 40 | 35.9 | 36.8 | signal |
| 7 | Chronic Kidney Disease | 203 | 32.0 | 36.0 | signal |
| 8 | Bone Density Decreased | 83 | 31.6 | 33.2 | signal |
| 9 | Emotional Distress | 278 | 27.6 | 32.7 | signal |
| 10 | Osteoporosis | 92 | 26.9 | 28.4 | signal |
| 11 | Nephropathy | 17 | 21.8 | 22.0 | signal |
| 12 | Multiple Fractures | 29 | 21.1 | 21.4 | signal |
| 13 | Vitamin D Deficiency | 15 | 18.5 | 18.7 | signal |
| 14 | Proteinuria | 29 | 18.5 | 18.8 | signal |
| 15 | Glomerular Filtration Rate Decreased | 17 | 16.9 | 17.1 | signal |
| 16 | Tooth Loss | 26 | 15.0 | 15.2 | signal |
| 17 | Loss Of Personal Independence In Daily Activities | 55 | 13.9 | 14.4 | signal |
| 18 | Foot Fracture | 20 | 12.7 | 12.8 | signal |
| 19 | Product Dose Omission Issue | 295 | 12.5 | 14.8 | signal |
| 20 | Renal Tubular Necrosis | 10 | 12.3 | 12.3 | signal |
| 21 | Anxiety | 285 | 12.0 | 14.2 | signal |
| 22 | Renal Failure | 132 | 11.9 | 12.8 | signal |
| 23 | Blood Creatinine Increased | 64 | 11.8 | 12.2 | signal |
| 24 | Bone Loss | 14 | 11.1 | 11.2 | signal |
| 25 | Renal Impairment | 77 | 11.1 | 11.6 | signal |
| 26 | Dialysis | 12 | 10.2 | 10.2 | signal |
| 27 | Ankle Fracture | 13 | 10.1 | 10.2 | signal |
| 28 | Skeletal Injury | 8 | 9.2 | 9.2 | signal |
| 29 | Rib Fracture | 15 | 8.8 | 8.9 | signal |
| 30 | Renal Pain | 7 | 8.0 | 8.0 | signal |
| 31 | Renal Disorder | 29 | 7.5 | 7.6 | signal |
| 32 | Inability To Afford Medication | 6 | 7.3 | 7.4 | signal |
| 33 | Renal Injury | 18 | 7.2 | 7.3 | signal |
| 34 | Polyneuropathy | 7 | 7.1 | 7.1 | signal |
| 35 | Peripheral Coldness | 8 | 7.0 | 7.0 | signal |
| 36 | Hepatitis C | 7 | 6.9 | 6.9 | signal |
| 37 | Acute Kidney Injury | 87 | 6.9 | 7.2 | signal |
| 38 | Drug Resistance | 14 | 6.6 | 6.6 | signal |
| 39 | Arteriosclerosis | 5 | 6.4 | 6.4 | signal |
| 40 | Depression | 120 | 6.3 | 6.7 | signal |
| 41 | Therapy Change | 5 | 6.2 | 6.3 | signal |
| 42 | Impaired Work Ability | 11 | 6.2 | 6.2 | signal |
| 43 | Dysstasia | 15 | 6.2 | 6.2 | signal |
| 44 | Decreased Immune Responsiveness | 5 | 6.2 | 6.2 | signal |
| 45 | Coeliac Disease | 5 | 6.1 | 6.1 | signal |
| 46 | Product Dispensing Error | 11 | 6.1 | 6.1 | signal |
| 47 | Pain | 311 | 6.1 | 7.2 | signal |
| 48 | Bursitis | 6 | 6.0 | 6.0 | signal |
| 49 | Osteonecrosis | 16 | 5.8 | 5.9 | signal |
| 50 | Infusion Site Pain | 6 | 5.7 | 5.7 | signal |
| 51 | Poisoning Deliberate | 4 | 5.2 | 5.2 | signal |
| 52 | Folliculitis | 4 | 4.7 | 4.7 | signal |
| 53 | Fracture | 7 | 4.5 | 4.5 | signal |
| 54 | Upper Limb Fracture | 7 | 4.2 | 4.2 | signal |
| 55 | Exposure During Pregnancy | 21 | 4.1 | 4.1 | signal |
| 56 | Hepatic Cytolysis | 4 | 3.9 | 3.9 | signal |
| 57 | Product Storage Error | 25 | 3.5 | 3.5 | signal |
| 58 | Nephropathy Toxic | 3 | 3.2 | 3.2 | no signal |
| 59 | Product Dose Omission In Error | 7 | 3.1 | 3.1 | signal |
| 60 | Product Dose Omission | 17 | 3.1 | 3.1 | signal |
| 61 | Extra Dose Administered | 7 | 2.1 | 2.1 | no signal |
| 62 | Circumstance Or Information Capable Of Leading To Medication Error | 5 | 1.8 | 1.8 | no signal |
| 63 | Oesophageal Carcinoma | 4 | 1.6 | 1.6 | no signal |
| 64 | Gynaecomastia | 3 | 1.2 | 1.2 | no signal |